Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 26, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2017View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-132

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information